NCT05205733

Brief Summary

The investigators currently lack an understanding of barriers to completing the male factor infertility evaluation. Furthermore, as the investigators continue to expand access to fertility treatment particularly within low-resourced settings, it is important that all aspects of infertility within a couple are equally explored. The COVID-19 pandemic has disproportionately affected low-income communities and communities of color at greater rates in terms of not only disease morbidity/mortality but how medical systems are accessed and care is delivered.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started May 2022

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 25, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

May 24, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

2 years

First QC Date

January 11, 2022

Last Update Submit

February 15, 2024

Conditions

Keywords

DisparitiesResource limitedLow-resource communities

Outcome Measures

Primary Outcomes (1)

  • To compare the time to complete the semen analysis with in-clinic versus at-home testing.

    The time to completion between in-clinic versus at-home testing will be identified when the provider obtains the results.

    3 months after consented to the study.

Secondary Outcomes (4)

  • To identify barriers to completing a semen analysis.

    Three months after being consented to the study.

  • To compare barriers unique to completing an in-clinic versus at-home testing.

    Three months after being consented to the study.

  • To compare satisfaction scores with in-clinic versus at-home testing.

    Three months after being consented to the study.

  • To compare the time to initiating treatment after completing in-clinic versus at-home testing.

    Six months after being consented to the study.

Study Arms (2)

In-Clinic Semen Analysis Testing

NO INTERVENTION

Men needing semen analysis for infertility work-up.

No in-clinic semen analysis testing

EXPERIMENTAL

Men needing semen analysis for infertility work-up.

Other: Mail-in semen analysis kit

Interventions

Presumably an easier, convenient, and more comfortable way to provide a semen analysis with an in-home mail-in semen analysis kit

Also known as: Fellow Health Semen Analysis
No in-clinic semen analysis testing

Eligibility Criteria

Age18 Years - 64 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All English or Spanish speaking male partners of female patients undergoing an infertility work-up evaluation at Zuckerberg San Francisco General Hospital and recommended to undergo a semen analysis as a part of this workup.

You may not qualify if:

  • If they do not speak English or Spanish they will be excluded
  • If they are under the age of 18 y.o
  • If they are not recommended to undergo a semen analysis as a part of the infertility evaluation
  • If they are unable to produce a semen sample.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Francisco

San Francisco, California, 94107, United States

RECRUITING

Related Publications (5)

  • Bradshaw A, Ballon-Landa E, Owusu R, Hsieh TC. Poor Compliance With Postvasectomy Semen Testing: Analysis of Factors and Barriers. Urology. 2020 Feb;136:146-151. doi: 10.1016/j.urology.2019.10.026. Epub 2019 Nov 26.

    PMID: 31778681BACKGROUND
  • Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril. 2015 Mar;103(3):e18-25. doi: 10.1016/j.fertnstert.2014.12.103. Epub 2015 Jan 15.

    PMID: 25597249BACKGROUND
  • Infertility Workup for the Women's Health Specialist: ACOG Committee Opinion, Number 781. Obstet Gynecol. 2019 Jun;133(6):e377-e384. doi: 10.1097/AOG.0000000000003271.

    PMID: 31135764BACKGROUND
  • Ethics Committee of the American Society for Reproductive Medicine. Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion. Fertil Steril. 2015 Nov;104(5):1104-10. doi: 10.1016/j.fertnstert.2015.07.1139. Epub 2015 Sep 10.

    PMID: 26364838BACKGROUND
  • Herndon CN, Anaya Y, Noel M, Cakmak H, Cedars MI. Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban community. Fertil Steril. 2017 Oct;108(4):642-649.e4. doi: 10.1016/j.fertnstert.2017.06.035. Epub 2017 Sep 2.

    PMID: 28874259BACKGROUND

MeSH Terms

Conditions

Infertility, Male

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Study Officials

  • Yanett Anaya, M.D.

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alisha T Tolani, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Participants are assigned to complete either a mail-in or in-clinic semen analysis.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2022

First Posted

January 25, 2022

Study Start

May 24, 2022

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

February 20, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations